Author/Authors :
Amparo Andrés-Pons، نويسنده , , Amparo and Valiente، نويسنده , , Miguel and Torres، نويسنده , , Josema and Gil، نويسنده , , Anabel and Roglل، نويسنده , , Isabel and Ripoll، نويسنده , , Francisca and Cervera، نويسنده , , Javier and Pulido، نويسنده , , Rafael، نويسنده ,
Abstract :
The binding of PTEN to PDZ-domain-containing proteins appears to play an important role in the control of cell growth, motility and apoptosis. In turn, this binding can be abrogated by cleavage of the PTEN C-terminal region by caspase-3. We have generated and characterized monoclonal antibodies (mAb) directed against distinct epitopes at the C-terminal region of PTEN, and used them to define protein-binding epitopes on PTEN and to study its cleavage by caspase-3. mAb directed against epitopes at the far C-terminus of PTEN blocked binding to PTEN cognate PDZ domains and did not recognize the caspase-3 cleaved PTEN fragments. On the other hand, mAb that recognized an epitope within the C2 domain of PTEN did not prevent binding to PDZ domains, but could detect the caspase-3 cleaved PTEN fragments. The analysis of PTEN cleavage by caspase-3 revealed that the lipid phosphatase activity of PTEN controls its own degradation by interfering with the PI3-K anti-apoptotic activity. Our results define protein-binding sites on the PTEN tumor suppressor at the immunochemical level, and suggest a regulatory link between PTEN phosphatase activity, caspase-3 sensitivity and PTEN-protein interactions.
Keywords :
Protein–protein interactions , caspase-3 , PTEN , Tumor suppressor phosphatase